Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Participating in Scottish Stratified Medicine Initiative

NEW YORK (GenomeWeb News) – Life Technologies today announced its participation in the Stratified Medicine Scotland Innovation Centre, or SMS-IC, a collaboration among academic, industrial, and the UK's National Health Service community to create a stratified medicine research infrastructure.

Life Tech is the lead commercial partner in SMS-IC along with biomedical informatics firm Aridhia, and the Ion Proton benchtop sequencer will be used as the primary tool "to drive discovery and genetic analysis."

The goal of SMS-IC is to "prove the principle of stratified clinical trials," and a number of projects will be initiated this year linking patient phenotype, genotype, and other data that enable the targeting of specific populations for clinical trials. Ion Torrent is for research-use only, but Life Tech said that, ultimately, the goal is to progress stratified clinical trial models from concept to clinical use.

In addition, SMS-IC will hold a competition to identify appropriate projects, Life Tech said.

"The vision for this project is to combine an individual's detailed genomic data with more traditional patient information to enable faster, more accurate, and effective clinical decisions," Peter Silvester, president of Europe, Middle East, and Africa of Life Technologies, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.